Bone Fracture Pipeline Therapeutics Development Review H2 2015

Press Release   •   Jan 07, 2016 08:37 EST

This report provides comprehensive information on the therapeutic development for Bone Fracture, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Fracture and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Complete report on H2, 2015 Pipeline Review of “Bone Fracture” addition with 30 market data tables and 15 figures, spread across 81 pages is .

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Companies Discussed/Mentioned in this Research:

Arcarios BV, AstraZeneca Plc, Biogenomics Limited, Biopharm GmbH, Bone Therapeutics SA, Juventas Therapeutics, Inc., Kaken Pharmaceutical Co., Ltd., Kolon Life Science, Inc., Kuros Biosurgery AG, Novartis AG, OrgaNext Research BV, TissueGene, Inc. and Viking Therapeutics, Inc.

Drugs Profile Discussed in this Research:

(nandrolone decanoate + cholecalciferol), ALLOB, AZD-2858, bimagrumab, denosumab biosimilar, dibotermin alfa, Drugs to Modulate Bone Morphogenetic Protein for Osteoarthritis and Fracture, Drugs to Modulate PPAR-Delta for Immunology, Metabolic and Musculoskeletal Disorders, Gene Therapy for Bone Fracture, JVS-200, K-436, KCB-1B, KLS-Bfr, KUR-111, KUR-113, LWnt-3a, Recombinant Protein for Degenerative Disc Disease, Bone Fracture, Parkinson's Disease and Erectile Dysfunction, Recombinant Protein to Activate TNF alfa for Fracture Repair, Small Molecules for Immunology, Metabolic and Musculoskeletal Disorders, Small Molecules for Immunology, Musculoskeletal and Metabolic Disorders, Stromal Cell Therapy for Fracture Repair, Synthetic Peptide for Osteoporosis and Bone Fracture, TG-B and VK-5211

Inquire before buying for this report .(This is a premium report price at US$2000 for a single user PDF license)


  • The report provides a snapshot of the global therapeutic landscape of Bone Fracture
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Bone Fracture and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Bone Fracture products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Bone Fracture pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy:

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Bone Fracture
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Bone Fracture pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Explore More Research Report on Orthopedic Therapeutics Market.

Orthopedics is a branch of science which deals with the study of disorders related to muscular and the skeletal system. When we talk of orthopedic therapeutics, we intend to talk of the right ways of treating the different disorders of the muscular and the skeletal system of human body.

With the help of orthopedic therapeutics, you can bid goodbye to these troubles as these are some of the finest ways of dealing with such joint troubles. Physical exercise when done in the right way can eliminate problems of rigid back or stiffness of body muscles. Yoga is slowly becoming one of the preferred methods for combating with problems of muscles and joints. Healthy diet and jogging can also beat a lot of such troubles as they are essential to staying fit. There are a lot of points that you should follow for keeping muscle problems at bay. is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries